Regulators discuss accelerated approvals, Project Orbis at DIA

Regulators from the US Food and Drug Administration (FDA), European Medicines Agency (EMA) and Health Canada gave their perspectives on different issues related to accelerated approval pathways in their respective jurisdictions at the Drug Industry Association’s (DIA) Global Annual Meeting.